Anti-Amyloid beta A4 protein [LY2062430 (Solanezumab, hu266)], IgG1, Clone: [LY2062430 Solanezumab hu266], Human, Monoclonal

Produktübersicht

• Artikelname: Anti-Amyloid beta A4 protein [LY2062430 (Solanezumab, hu266)], IgG1, Clone: [LY2062430 Solanezumab hu266], Human, Monoclonal
• Artikelnummer: ABA-AB04185-10.0-BT
• Hersteller Artikelnummer: Ab04185-10.0-BT
• Alternativnummer: ABA-AB04185-10.0-BT
• Hersteller: Absolute Antibody
• Wirt: Human
• Kategorie: Antikörper
• Applikation: ELISA
• Spezies Reaktivität: Human
• Alternative Synonym: APP, Abeta peptide, Abeta, A-beta, Abeta, Abeta42, amyloid beta peptide, Alzheimer disease amyloid protein, Beta-amyloid precursor protein, Protease nexin-II, humanized m266.2

Produktbeschreibung

The parental mouse antibody 266 was generated by immunization of mice with a peptide composed of residues 13-28 of human Abeta peptide. The original humanized version of the antibody was generated by grafting CDRs of the mouse antibody onto human framework

Produkteigenschaften

• Klonalität: Monoclonal
• Klon-Bezeichnung: [LY2062430 Solanezumab hu266]
• Isotyp: IgG1
• UniProt: P05067
• Puffer: PBS only.
• Target-Kategorie: Amyloid beta A4 protein